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The transplantation of pancreatic islet cells is a promising alternative to insulin injections for patients with type 1 
diabetes.  Encapsulating islet cells in alginate provides an immunoprotective barrier between the graft and host 
immune system, which can circumvent the need for chronic immunosuppression post transplantation, while still 
allowing for oxygen and nutrient transfer to the cells.  Current nozzle-based cell encapsulation methods limit the 
viscosity of alginate that can be used, resulting in antibody permeability; a stirred emulsification encapsulation 
method results in beads that are polydisperse in size, which may lead to diffusion limitations in larger beads and 
improper cell encapsulation in smaller beads.  Microchannel emulsification is an alternative emulsion technique 
to produce uniform-sized droplets.  This technique can be used to produce both oil-in-water and water-in-oil 
emulsions at high production rates with dispersed phase droplets ranging from microns to millimeters in 
diameter.  The to-be-dispersed phase flows through oblong microchannels in a thin plate, forming droplets into 
the continuous phase due to hydrodynamic instability at the exit of the channels.  The objective of this work was 
to develop microchannel emulsification for production of uniformly sized, highly concentrated alginate beads at 
clinically relevant production rates for encapsulation of islet cells for transplantation.  The microchannel plate 
and dual-flow chamber system were both designed and produced to allow for flow on either side of the mounted 
microchannel plate (Figure 1).  Initial attempts to produce alginate beads resulted in jetting, visualized as a 
continuous outflow and expansion of the alginate.  Significant modifications to the processing fluids and set-up 
resulted in the production of uniform spherical alginate beads in the range of 2 – 4 mm in diameter, with a 
coefficient of variation of <10%.  The size of the alginate beads was found to be independent of the alginate flow 
rate up to a critical flow rate, above which jetting was observed.  Current operating conditions result in bead 
production rates of approximately 4 mL/minute per microchannel.  However, if the size of the beads was 
reduced to the desired 600 µm in diameter while maintaining the same frequency of bead production, the 
production rate would decrease to approximately 2 mL/hour per microchannel.  To produce the 100 mL 
necessary to treat one patient in one hour, 50 microchannels would then be required.  Current work is focused 
on characterizing the physiochemical properties of the beads, including surface roughness, strength, and 
stability.  Mouse Insulinoma 6 (MIN6) cells will then be encapsulated using the microchannel emulsification 
process.  Cell recovery, survival, and function, including glucose-responsive insulin secretion, will be assessed.  
This work demonstrates the feasibility of using microchannel emulsification for the production of uniform, highly 




Figure 1 – Principle and set-up of microchannel emulsification 
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